In a retrospective study, the authors showed that CVID and IgE-deficient patients are more likely to develop lymphoma and uterine cancer, whereas non-CVID + IgE-deficient patients are more prone to malignancies—lymphoma, myeloma, breast cancer, and kidney cancer [35]. This evidence concerns the gene IGHE and uterine cancer.